Sono-Tek Corporation filings document formal disclosures for a New York operating company that manufactures precision ultrasonic coating systems. Recent Form 8-K reports furnish quarterly operating results, Regulation FD materials, annual meeting presentations, and press releases tied to significant medical device coating system orders. Proxy and shareholder-meeting filings cover board elections, director service changes, auditor ratification, security-holder voting results, and governance matters.
Sono-Tek Corp Vice President Brian Lewis Booth reported exercising vested stock options and adjusting his equity position in the company. On May 1, 2026, he exercised options into Sono-Tek Corp Common Stock at prices of $5.48, $4.45, and $4.12 per share.
Footnotes state that Booth exercised vested options and surrendered 3,299 shares of Sono-Tek Common Stock as payment for the option exercise, a non‑market transfer rather than an open‑market sale. Following these transactions, he continues to hold common stock directly and retains 12,153 Sono-Tek Corp Options with future expiration dates, reflecting an ongoing equity stake tied to the company’s performance.
Sono-Tek Corp VP Brian Lewis Booth has filed an initial insider ownership report. The filing shows he directly holds 653 shares of Sono-Tek Corp common stock. It also lists three option positions over Sono-Tek Corp stock, all held directly.
These options are exercisable for 1,650 shares at an exercise price of $4.45 per share expiring in 2034, 5,792 shares at $4.12 per share expiring in 2034, and 7,317 shares at $3.25 per share expiring in 2035. The filing records these as existing holdings rather than new market transactions.
Sono-Tek Corp director Lawal Adeniyi reported two related transactions. He bought 2,400 shares of common stock at $4.12 per share in an open-market purchase and simultaneously disposed of 2,400 stock options back to the company at the same price. Following these moves, he holds 2,400 common shares directly and 9,951 options on Sono-Tek stock.
Sono-Tek Corporation reported improved profitability for its third quarter of fiscal 2026 despite nearly flat sales. Net sales for the quarter were $5.0 million, down 3.6% from $5.19 million a year earlier, but gross margin expanded to 50% from 45% as product mix shifted toward higher-margin systems and U.S. sales with lower distributor discounts. Operating income rose to $319,000, up 61% from $198,000, and net income increased 24% to $340,000.
For the first nine months of fiscal 2026, revenue was essentially flat at $15.3 million, while net income grew 32% to $1.25 million as gross profit improved to $7.77 million and gross margin reached 51%. The company ended the period with no debt and cash, cash equivalents and marketable securities totaling $12.26 million, and reported a record combined equipment and service backlog of $12.26 million, up 16% year over year. Shares outstanding were 15,710,389 as of January 9, 2026.
Sono-Tek Corporation filed a current report to notify investors that it has released a press release with its financial results for the quarter ended November 30, 2025. The press release is included as Exhibit 99.1 to the report and provides details on the company’s results of operations and financial condition for that quarter.
The company notes that the information in the furnished exhibit, including the press release, is being provided under Regulation FD and is not considered filed for liability purposes under the Securities Exchange Act. The report is signed by the company’s Chief Financial Officer, Stephen J. Bagley.
Sono-Tek Corporation furnished a press release announcing financial results for the quarter ended August 31, 2025. The company reported this under Item 2.02 and included Regulation FD disclosure under Item 7.01. The release is attached as Exhibit 99.1 and is designated as “furnished,” not “filed,” under the Exchange Act.
Sono‑Tek (SOTK) disclosed an insider transaction. Director Christopher Coccio sold 12,320 shares of common stock on 10/23/2025 at a weighted average price of $4.7803 (Transaction Code: S). Following the sale, he beneficially owns 309,447 shares, held directly.
The footnote states the sale was executed in multiple trades at prices ranging from $4.77 to $4.89, and detailed trade breakdowns are available upon request.
Sono-Tek (SOTK) director Christopher Coccio reported open-market sales of common stock. On 10/21/2025, he sold 100 shares at $4.665, 100 shares at $4.67, 2,097 shares at $4.66, and 2,015 shares at $4.65. Following these transactions, he beneficially owns 321,767 shares, held directly.
This is a routine Form 4 disclosure of insider transactions and changes in direct ownership.
Sono-Tek (SOTK) reported Q2 FY26 results with net sales of $5,163,000 and diluted EPS of $0.03. Gross profit was $2,590,000 with a 50.2% gross margin. Operating income rose to $421,000, a 47% increase year over year as higher-margin mix and lower operating expenses helped results.
Medical sales grew 150% on balloon coating shipments, while Alternative/Clean Energy was steady and Electronics/Microelectronics held near prior-year levels. APAC revenue increased 153% driven by medical and energy orders, partially offsetting a 22% decline in the U.S. and Canada. Backlog was $11,210,000 at August 31, 2025, up 50% sequentially from Q1.
For the first half, sales were $10,296,000 and operating income $905,000 (up 73%). Cash, cash equivalents and marketable securities totaled $10,568,000 with no outstanding debt. Operating cash flow was $(1,099,000), reflecting higher accounts receivable tied to revised timing on a $4.4 million multi-unit order.
Sono-Tek Corporation reported via an 8-K that it issued a press release announcing an order for medical device coating systems valued at $2.8 million.
The disclosure was furnished under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure) and includes Exhibit 99.1, a press release dated October 13, 2025. The furnished information is not deemed filed under Section 18 of the Exchange Act.